Michael R. Minogue - Mar 31, 2022 Form 4 Insider Report for ABIOMED INC (NASD)

Role: CHAIRMAN, PRESIDENT, CEO, Director
Signature: /s/ Marc A. Began (by power of attorney)
Stock symbol: NASD
Transactions as of: Mar 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/4/2022, 05:14 PM
Previous filing: May 26, 2022
Next filing: May 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NASD	Common Stock $.01 par value	Award	$0	+43	+0.02%	$0.00	230K	Mar 31, 2022	Direct	F1
holding	NASD	Common Stock $.01 par value						52.6K	Mar 31, 2022	By Trust - A
holding	NASD	Common Stock $.01 par value						73.7K	Mar 31, 2022	By Trust - B
holding	NASD	Common Stock $.01 par value						32.8K	Mar 31, 2022	By Trust - C
holding	NASD	Common Stock $.01 par value						655	Mar 31, 2022	By Trust - D
holding	NASD	Common Stock $.01 par value						38.6K	Mar 31, 2022	By Trust - E
holding	NASD	Common Stock $.01 par value						85K	Mar 31, 2022	By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NASD	Stock Option (right to buy)						85K	Mar 31, 2022	Common Stock	0	$21.55	Direct	F2, F3
holding	NASD	Stock Option (right to buy)						35K	Mar 31, 2022	Common Stock	0	$66.25	Direct	F2, F3
holding	NASD	Stock Option (right to buy)						30.5K	Mar 31, 2022	Common Stock	0	$99.62	Direct	F3, F4
holding	NASD	Stock Option (right to buy)						33K	Mar 31, 2022	Common Stock	0	$134.51	Direct	F3, F4
holding	NASD	Stock Option (right to buy)						30K	Mar 31, 2022	Common Stock	0	$381.97	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						50K	Mar 31, 2022	Common Stock	0	$266.39	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						20.9K	Mar 31, 2022	Common Stock	0	$223.90	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						30K	Mar 31, 2022	Common Stock	0	$283.88	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).
F2	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4	. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.